From: Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
Patient clinical data | n/N | Percent |
---|---|---|
Age at diagnosis | ||
< 65 | 34/69 | 49 |
≥ 65 | 35/69 | 51 |
Sex | ||
Male | 36/69 | 52 |
Female | 33/69 | 48 |
Tumor size (mm) | ||
< 30 | 23/69 | 33 |
30–40 | 31/69 | 45.0 |
> 40 | 15/69 | 22 |
Tumor stage | ||
I | 18/68 | 26 |
II | 44/68 | 65 |
III–IV | 6/68 | 9 |
Lymph nodes* | ||
Negative | 34/68 | 50 |
Positive | 34/68 | 50 |
HIF-1alpha | ||
Strong | 28/64 | 44 |
Weak | 36/64 | 56 |
BMI** | ||
< 25 | 19/46 | 41 |
> 25 | 27/46 | 59 |
Smoking | ||
Smoker** | 14/33 | 42 |
Ex-smoker | 7/33 | 21 |
Non-smoker | 12/33 | 36 |
Alcohol usage** | ||
Heavy | 7/24 | 29 |
Moderate-No | 17/24 | 71 |
Chronic pancreatitis*** | ||
Present | 39/69 | 57 |
Absent | 30/69 | 43 |